M. Ikoma, T. Kawamura, and Y. Kakinuma, Cause of variable therapeutic efficiency of angiotensin converting enzyme inhibitor on glomerular lesions, Kidney International, vol.40, issue.2, pp.195-202, 1991.
DOI : 10.1038/ki.1991.200

M. Flamant, S. Placier, and A. Rodenas, Discoidin Domain Receptor 1 Null Mice Are Protected against Hypertension-Induced Renal Disease, Journal of the American Society of Nephrology, vol.17, issue.12, pp.3374-3381, 2006.
DOI : 10.1681/ASN.2006060677

N. Shweke, N. Boulos, and C. Jouanneau, Tissue transglutaminase contributes to interstitial renal fibrosis by favoring accumulation of fibrillar collagen through TGF-beta activation and cell infiltration

M. Flamant, S. Placier, and C. Dubroca, Role of Matrix Metalloproteinases in Early Hypertensive Vascular Remodeling, Hypertension, vol.50, issue.1, pp.212-218, 2007.
DOI : 10.1161/HYPERTENSIONAHA.107.089631

C. Chatziantoniou, J. Boffa, and R. Ardaillou, Nitric oxide inhibition induces early activation of type I collagen gene in renal resistance vessels and glomeruli in transgenic mice. Role of endothelin., Journal of Clinical Investigation, vol.101, issue.12, pp.2780-2789, 1998.
DOI : 10.1172/JCI2132

F. Helle, C. Jouzel, and C. Chadjichristos, Improvement of renal hemodynamics during hypertension-induced chronic renal disease: role of EGF receptor antagonism, AJP: Renal Physiology, vol.297, issue.1, pp.191-199, 2009.
DOI : 10.1152/ajprenal.00015.2009

J. Boffa, Y. Lu, and S. Placier, Regression of Renal Vascular and Glomerular Fibrosis: Role of Angiotensin II Receptor Antagonism and Matrix Metalloproteinases, Journal of the American Society of Nephrology, vol.14, issue.5, pp.1132-1144, 2003.
DOI : 10.1097/01.ASN.0000060574.38107.3B

A. Huby, M. Rastaldi, and K. Caron, Restoration of Podocyte Structure and Improvement of Chronic Renal Disease in Transgenic Mice Overexpressing Renin, PLoS ONE, vol.23, issue.8, p.6721, 2009.
DOI : 10.1371/journal.pone.0006721.t001

M. Adamczak, M. Gross, and J. Krtil, Reversal of Glomerulosclerosis after High-Dose Enalapril Treatment in Subtotally Nephrectomized Rats, Journal of the American Society of Nephrology, vol.14, issue.11, pp.2833-2842, 2003.
DOI : 10.1097/01.ASN.0000095248.91994.D3

G. Piecha, N. Koleganova, and M. Gross, Regression of glomerulosclerosis in subtotally nephrectomized rats: effects of monotherapy with losartan, spironolactone, and their combination, AJP: Renal Physiology, vol.295, issue.1, pp.137-144, 2008.
DOI : 10.1152/ajprenal.00065.2008

T. Ohtake, M. Oka, and K. Maesato, Pathological Regression by Angiotensin II Type 1 Receptor Blockade in Patients with Mesangial Proliferative Glomerulonephritis, Hypertension Research, vol.31, issue.3, pp.387-394, 2008.
DOI : 10.1291/hypres.31.387

E. Lazzeri, B. Mazzinghi, and P. Romagnani, Regeneration and the kidney, Current Opinion in Nephrology and Hypertension, vol.19, issue.3, pp.248-253, 2010.
DOI : 10.1097/MNH.0b013e32833680dc

J. Menke, Y. Iwata, and W. Rabacal, CSF-1 signals directly to renal tubular epithelial cells to mediate repair in mice, Journal of Clinical Investigation, vol.119, issue.8, pp.2330-2334, 2009.
DOI : 10.1172/JCI39087DS1

R. Chevalier, M. Forbes, and B. Thornhill, Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy, Kidney International, vol.75, issue.11, pp.1145-1152, 2009.
DOI : 10.1038/ki.2009.86

K. Ito, J. Chen, E. Chaar, and M. , Renal damage progresses despite improvement of renal function after relief of unilateral ureteral obstruction in adult rats, AJP: Renal Physiology, vol.287, issue.6, pp.1283-1293, 2004.
DOI : 10.1152/ajprenal.00441.2003

R. Chevalier, B. Thornhill, and A. Chang, Recovery from release of ureteral obstruction in the rat: Relationship to nephrogenesis, Kidney International, vol.61, issue.6, pp.2033-2043, 2002.
DOI : 10.1046/j.1523-1755.2002.00359.x

J. Koo, Y. Kim, and S. Rozen, Enalapril accelerates remodeling of the renal interstitium after release of unilateral ureteral obstruction in rats, J Nephrol, vol.16, pp.203-209, 2003.

A. Cochrane, M. Kett, and C. Samuel, Renal Structural and Functional Repair in a Mouse Model of Reversal of Ureteral Obstruction, Journal of the American Society of Nephrology, vol.16, issue.12, pp.3623-3623, 2005.
DOI : 10.1681/ASN.2004090771

S. Crawford, V. Stellmach, and J. Murphy-ullrich, Thrombospondin-1 Is a Major Activator of TGF-??1 In Vivo, Cell, vol.93, issue.7, pp.1159-1170, 1998.
DOI : 10.1016/S0092-8674(00)81460-9

J. Isenberg, G. Martin-manso, and J. Maxhimer, Regulation of nitric oxide signalling by thrombospondin 1: implications for anti-angiogenic therapies, Nature Reviews Cancer, vol.14, issue.3, pp.182-194, 2009.
DOI : 10.1038/nrc2561

C. Carlson, J. Lawler, and D. Mosher, Thrombospondins: from structure to therapeutics, Cellular and Molecular Life Sciences, vol.65, issue.5, pp.672-686, 2008.
DOI : 10.1007/s00018-007-7484-1

R. Kalluri and E. Neilson, Epithelial-mesenchymal transition and its implications for fibrosis, Journal of Clinical Investigation, vol.112, issue.12, pp.1776-1784, 2003.
DOI : 10.1172/JCI200320530

T. Tapmeier, K. Brown, and Z. Tang, Reimplantation of the ureter after unilateral ureteral obstruction provides a model that allows functional evaluation, Kidney International, vol.73, issue.7, pp.885-889, 2008.
DOI : 10.1038/sj.ki.5002797

T. Puri, M. Shakaib, and A. Chang, Chronic kidney disease induced in mice by reversible unilateral ureteral obstruction is dependent on genetic background, AJP: Renal Physiology, vol.298, issue.4, pp.1024-1032, 2010.
DOI : 10.1152/ajprenal.00384.2009

T. Wada, K. Furuichi, and N. Sakai, Gene Therapy via Blockade of Monocyte Chemoattractant Protein-1 for Renal Fibrosis, Journal of the American Society of Nephrology, vol.15, issue.4, pp.940-948, 2004.
DOI : 10.1097/01.ASN.0000120371.09769.80

M. Nishida and K. Hamaoka, Macrophage Phenotype and Renal Fibrosis in Obstructive Nephropathy, Nephron Experimental Nephrology, vol.110, issue.1, pp.31-36, 2008.
DOI : 10.1159/000151561

S. Ricardo, H. Van-goor, and A. Eddy, Macrophage diversity in renal injury and repair, Journal of Clinical Investigation, vol.118, issue.11, pp.3522-3530, 2008.
DOI : 10.1172/JCI36150

S. Lin, B. Li, and S. Rao, Macrophage Wnt7b is critical for kidney repair and regeneration, Proceedings of the National Academy of Sciences, vol.107, issue.9, pp.4194-4199, 2010.
DOI : 10.1073/pnas.0912228107

M. Sato, Y. Muragaki, and S. Saika, Targeted disruption of TGF-??1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction, Journal of Clinical Investigation, vol.112, issue.10, pp.1486-1494, 2003.
DOI : 10.1172/JCI200319270

M. Pepper, Transforming growth factor-beta: Vasculogenesis, angiogenesis, and vessel wall integrity, Cytokine & Growth Factor Reviews, vol.8, issue.1, pp.21-43, 1997.
DOI : 10.1016/S1359-6101(96)00048-2

I. Nunes, P. Gleizes, and C. Metz, Latent Transforming Growth Factor-?? Binding Protein Domains Involved in Activation and Transglutaminase-dependent Cross-Linking of Latent Transforming Growth Factor-??, The Journal of Cell Biology, vol.267, issue.5, pp.1151-1163, 1997.
DOI : 10.1083/jcb.124.5.855

L. Ma, H. Yang, and A. Gaspert, Transforming Growth Factor-??-Dependent and -Independent Pathways of Induction of Tubulointerstitial Fibrosis in ??6???/??? Mice, The American Journal of Pathology, vol.163, issue.4, pp.1261-1273, 2003.
DOI : 10.1016/S0002-9440(10)63486-4

D. Kang, A. Joly, and S. Oh, Impaired angiogenesis in the remnant kidney model: I. Potential role of vascular endothelial growth factor and thrombospondin-1, J Am Soc Nephrol, vol.12, pp.1434-1447, 2001.

C. Daniel, K. Schaub, and K. Amann, Thrombospondin-1 Is an Endogenous Activator of TGF-?? in Experimental Diabetic Nephropathy In Vivo, Diabetes, vol.56, issue.12, pp.2982-2989, 2007.
DOI : 10.2337/db07-0551

B. Hohenstein, C. Daniel, and B. Hausknecht, Correlation of enhanced thrombospondin-1 expression, TGF-?? signalling and proteinuria in human type-2 diabetic nephropathy, Nephrology Dialysis Transplantation, vol.23, issue.12, pp.3880-3887, 2008.
DOI : 10.1093/ndt/gfn399

X. Zhang and J. Lawler, Thrombospondin-based antiangiogenic therapy, Microvascular Research, vol.74, issue.2-3, pp.90-99, 2007.
DOI : 10.1016/j.mvr.2007.04.007

Y. Ogata, S. Ishidoya, and A. Fukuzaki, Upregulated Expression of Transforming Growth Factor-.BETA., Type IV Collagen, and Plasminogen Activator Inhibitor-1 mRNA Are Decreased after Release of Unilateral Ureteral Obstruction., The Tohoku Journal of Experimental Medicine, vol.197, issue.3, pp.159-168, 2002.
DOI : 10.1620/tjem.197.159

J. Lawler, M. Sunday, and V. Thibert, Thrombospondin-1 is required for normal murine pulmonary homeostasis and its absence causes pneumonia., Journal of Clinical Investigation, vol.101, issue.5, pp.982-992, 1998.
DOI : 10.1172/JCI1684

D. Kang, S. Anderson, and Y. Kim, Impaired angiogenesis in the aging kidney: Vascular endothelial growth factor and Thrombospondin-1 in renal disease, American Journal of Kidney Diseases, vol.37, issue.3, pp.601-611, 2001.
DOI : 10.1053/ajkd.2001.22087

C. Daniel, J. Wiede, and H. Krutzsch, Thrombospondin-1 is a major activator of TGF-?? in fibrotic renal disease in the rat in vivo, Kidney International, vol.65, issue.2, pp.459-468, 2004.
DOI : 10.1111/j.1523-1755.2004.00395.x

C. Daniel, Y. Takabatake, and M. Mizui, Antisense Oligonucleotides Against Thrombospondin-1 Inhibit Activation of TGF-?? in Fibrotic Renal Disease in the Rat in Vivo, The American Journal of Pathology, vol.163, issue.3, pp.1185-1192, 2003.
DOI : 10.1016/S0002-9440(10)63478-5

K. Hochegger, S. Knight, and C. Hugo, Role of Thrombospondin-1 in the Autologous Phase of an Accelerated Model of Anti-Glomerular Basement Membrane Glomerulonephritis, Nephron Experimental Nephrology, vol.96, issue.2, pp.31-38, 2004.
DOI : 10.1159/000076402

C. Thakar, K. Zahedi, and M. Revelo, Identification of thrombospondin 1 (TSP-1) as a novel mediator of cell injury in kidney ischemia, Journal of Clinical Investigation, vol.116, issue.2, pp.3451-3459, 2005.
DOI : 10.1172/JCI25461C1

P. Grimbert, S. Bouguermouh, and N. Baba, Thrombospondin/CD47 Interaction: A Pathway to Generate Regulatory T Cells from Human CD4+CD25- T Cells in Response to Inflammation, The Journal of Immunology, vol.177, issue.6, pp.3534-3541, 2006.
DOI : 10.4049/jimmunol.177.6.3534

P. Miossec, T. Korn, and V. Kuchroo, Interleukin-17 and Type 17 Helper T Cells, New England Journal of Medicine, vol.361, issue.9, pp.888-898, 2009.
DOI : 10.1056/NEJMra0707449

A. Agah, T. Kyriakides, and J. Lawler, The Lack of Thrombospondin-1 (TSP1) Dictates the Course of Wound Healing in Double-TSP1/TSP2-Null Mice, The American Journal of Pathology, vol.161, issue.3
DOI : 10.1016/S0002-9440(10)64243-5

H. Paust, J. Turner, and O. Steinmetz, The IL-23/Th17 Axis Contributes to Renal Injury in Experimental Glomerulonephritis, Journal of the American Society of Nephrology, vol.20, issue.5, pp.969-979, 2009.
DOI : 10.1681/ASN.2008050556

K. Yang, J. Vega, and M. Hadzipasic, Deficiency of thrombospondin-1 reduces Th17 differentiation and attenuates experimental autoimmune encephalomyelitis, Journal of Autoimmunity, vol.32, issue.2, pp.94-103, 2009.
DOI : 10.1016/j.jaut.2008.12.004

T. Lanz, Z. Ding, and P. Ho, Angiotensin II sustains brain inflammation in mice via TGF-??, Journal of Clinical Investigation, vol.120, issue.8, pp.2782-2794, 2010.
DOI : 10.1172/JCI41709DS1

S. Shetty, S. Kaushik, and M. Mojamdar, Viability testing of homograft valves using methyl thiazol tetrazolium assay, J Postgrad Med, vol.42, pp.72-75, 1996.

J. Bonheur, H. Albadawi, and G. Patton, A noninvasive murine model of hind limb ischemia-reperfusion injury, Journal of Surgical Research, vol.116, issue.1, pp.55-63, 2004.
DOI : 10.1016/S0022-4804(03)00232-4